Effects of low-dose aspirin on acute inflammatory responses in humans.
about
Activation of the annexin A1 pathway underlies the protective effects exerted by estrogen in polymorphonuclear leukocytesResolution of Inflammation: What Controls Its Onset?Aspirin as a potential treatment in sepsis or acute respiratory distress syndromeEicosanoid storm in infection and inflammationEmerging targets in neuroinflammation-driven chronic painEmerging roles of resolvins in the resolution of inflammation and painLipid mediators in the resolution of inflammationThe resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolutionFunctional Metabolomics Reveals Novel Active Products in the DHA MetabolomeProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeInflammation-a Critical Appreciation of the Role of Myeloid CellsResolution of acute inflammation in the lungPro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in InflammationEvidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptorPro-resolving lipid mediators are leads for resolution physiology.Specialized pro-resolving lipid mediators in the inflammatory response: An updateNovel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?Inflammation and its resolution as determinants of acute coronary syndromes.Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris.Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways.Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytesBlockade of leukocyte haptokinesis and haptotaxis by ketoprofen, diclofenac and SC-560.Phospholipase A2 regulates eicosanoid class switching during inflammasome activationPro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammationSpecific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediatorsProresolving lipid mediators and mechanisms in the resolution of acute inflammationAnti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites.MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits.Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brainProtective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect.Novel anti-inflammatory--pro-resolving mediators and their receptorsNon-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients.Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli.Novel proresolving aspirin-triggered DHA pathway
P2860
Q24618363-B756D5D7-3084-435B-9856-EE1C6D766D91Q26747410-70A29C43-16EB-4182-B61B-107E68430A2FQ26780333-8FDCC80E-15E4-47C8-9684-C7DD1E596408Q26851985-588E6F3B-12A8-4F97-93E4-4A46FDABE188Q28242435-5A69357C-C71C-4F28-8375-F726697BDFBCQ28249435-026067AB-E580-42B4-A56D-F4D73EFBED9CQ28250668-94E136B8-0EE3-426D-BEB4-C5B99A3E8748Q28260186-F0BF61B7-82F2-4B11-B71A-B123AF2D8C81Q28266178-42879BA2-5A3D-4681-9FF6-41E3A75D9A97Q28387661-42DDA832-421C-49CE-A4B3-0E1621E46E9DQ28595434-4213EE6C-A7F2-45CE-BFAF-2DDEC90E8E39Q28652204-7EF36979-9DCF-4A45-B08D-EDA508E9278EQ28716294-0651E496-415C-42EE-93F0-C9AF3E287F98Q30504456-C5A33362-867D-454F-BD47-94DF5F96E456Q30514238-9D5F8434-0AAD-4275-B36A-1D776FEF1B48Q30579732-FBCFA9F3-DBFE-4961-BBB4-84700C2215B9Q30829097-5AA56E22-CE7A-4299-B45B-5500EA352366Q33657562-E7393537-B16C-4128-904B-5EAC3B8CEBB6Q33683210-FECBD8A8-5B02-45F6-A903-DADF78A94316Q33834800-2976613D-C0CB-4BE7-825A-C4AE35B2AA1CQ33882297-F83F4D48-D057-4E3F-A897-881E4643D80AQ33895002-862D4575-CC37-4967-9326-9A3C739480DFQ33928544-10040D77-0298-43E9-8021-15CB6C85AA24Q34065741-0BAEBAA3-5CC7-40C3-8B94-6A368D9B91A2Q34073053-490C50D4-B475-4C32-B401-7AFC034F5DE6Q34144445-135B9634-29D0-4424-B1C7-B8533F3FAA2AQ34157528-6F6BE33D-8168-4213-910B-F4CA75EAB6CFQ34294883-C2D78388-E791-4D40-B20B-495983035043Q34411426-582D89E5-96B3-4B98-BAAA-1D2297F3B06DQ34444465-D118D28F-6CA1-486C-8744-20ECB3391474Q34502699-5DD39FFF-F295-4D97-88DA-C9F0C984768BQ34522097-F8972C6E-8784-41A1-B52A-EEE4C7F108D2Q34685370-0D27A7AE-3CC9-4F7C-98C0-F94B48D73C21Q34702419-D5FF61C9-F9C2-47C9-8B17-1EBD969F7440Q34982051-E103465B-7093-491A-913E-61B11B66602EQ34985170-AD30D636-FBAC-410A-AC4A-BF7AAF6B7CF0Q35069540-EA77CB33-1EA6-413E-97A9-BCCA5133EF81Q35098090-5B6A8489-BD98-425C-80F8-67084350C703Q35170024-CBCAE3A5-8011-4AA5-9F39-4A1DBF52F04AQ35189668-71DA905F-A6BB-465E-8339-E33D8FF17056
P2860
Effects of low-dose aspirin on acute inflammatory responses in humans.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effects of low-dose aspirin on acute inflammatory responses in humans.
@ast
Effects of low-dose aspirin on acute inflammatory responses in humans.
@en
Effects of low-dose aspirin on acute inflammatory responses in humans.
@nl
type
label
Effects of low-dose aspirin on acute inflammatory responses in humans.
@ast
Effects of low-dose aspirin on acute inflammatory responses in humans.
@en
Effects of low-dose aspirin on acute inflammatory responses in humans.
@nl
prefLabel
Effects of low-dose aspirin on acute inflammatory responses in humans.
@ast
Effects of low-dose aspirin on acute inflammatory responses in humans.
@en
Effects of low-dose aspirin on acute inflammatory responses in humans.
@nl
P2093
P50
P356
P1476
Effects of low-dose aspirin on acute inflammatory responses in humans
@en
P2093
Geoffrey Bellingan
Justine Newson
Melanie Stables
Patricia de Souza
Paul Colville-Nash
Thea Morris
P304
P356
10.4049/JIMMUNOL.0900477
P407
P577
2009-07-13T00:00:00Z